Search research articles
Contact Us
Filters
Showing results (271-280 of 311) with videos related to
Page
of 32
Sort By:
Plos One
|
September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?
Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
Joint Bone Spine
|
October 10, 2024
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
Bruno Fautrel, Joanna Kedra, Claire Rempenault, et al.
The Journal of Infection
|
October 10, 2022
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation
Xavier de Lamballerie, Guillaume Martin-Blondel, Axelle Dupont, et al.
Joint Bone Spine
|
October 19, 2025
Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease
Pierre-Antoine Juge, Marie-Pierre Debray, Valérie Devauchelle Pensec, et al.
Annals of the Rheumatic Diseases
|
September 24, 2021
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics
Renaud Felten, Pierre-Marie Duret, Elodie Bauer, et al.
Annals of the Rheumatic Diseases
|
January 21, 2014
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
Raphaèle Seror, Elke Theander, Johan G Brun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2021
Prevalence of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture-Recapture and Geospatial Analysis
Stéphane Giorgiutti, Yannick Dieudonne, Olivier Hinschberger, et al.
Annals of the Rheumatic Diseases
|
December 31, 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag, Kim Lauper, Juan Molina-Collada, et al.
Science Translational Medicine
|
July 26, 2013
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome
Sylvie Rusakiewicz, Gaetane Nocturne, Thierry Lazure, et al.
Arthritis and Rheumatism
|
May 28, 2010
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry
Benjamin Terrier, Zahir Amoura, Philippe Ravaud, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 311) with videos related to
Sort By:
Page
of 32
Plos One
|
September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?
Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
Joint Bone Spine
|
October 10, 2024
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
Bruno Fautrel, Joanna Kedra, Claire Rempenault, et al.
The Journal of Infection
|
October 10, 2022
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation
Xavier de Lamballerie, Guillaume Martin-Blondel, Axelle Dupont, et al.
Joint Bone Spine
|
October 19, 2025
Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease
Pierre-Antoine Juge, Marie-Pierre Debray, Valérie Devauchelle Pensec, et al.
Annals of the Rheumatic Diseases
|
September 24, 2021
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics
Renaud Felten, Pierre-Marie Duret, Elodie Bauer, et al.
Annals of the Rheumatic Diseases
|
January 21, 2014
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
Raphaèle Seror, Elke Theander, Johan G Brun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2021
Prevalence of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture-Recapture and Geospatial Analysis
Stéphane Giorgiutti, Yannick Dieudonne, Olivier Hinschberger, et al.
Annals of the Rheumatic Diseases
|
December 31, 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag, Kim Lauper, Juan Molina-Collada, et al.
Science Translational Medicine
|
July 26, 2013
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome
Sylvie Rusakiewicz, Gaetane Nocturne, Thierry Lazure, et al.
Arthritis and Rheumatism
|
May 28, 2010
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry
Benjamin Terrier, Zahir Amoura, Philippe Ravaud, et al.
Page
of 32